Company / Shares Outstanding
Apellis Pharmaceuticals, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
124.5M
FY2025
5-year range
76.1M / 124.5M
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#83 of 212
Health Care
What the data says
At 124495000.00, Apellis Pharmaceuticals, Inc.'s shares outstanding ranks #130 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 8428366.00 in FY2016 to 124495000.00 in FY2025.
Based on SEC 10-K filings.
124495000.00 in FY2025 with a 5-year CAGR of +14.3%.
Increased from 110772000.00 to 124495000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
#130 of 212 in Health CareTop 61% of 212This company 124.5M Sector average 306.7M
▼
-59.4% below sector average
Key checks
Key Insights
- Apellis Pharmaceuticals, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 4.1% year-over-year.
- Ranks #83 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 124.5M | +4.1% |
| FY2024 | 119.6M | +7.9% |
| FY2023 | 110.8M | +13.6% |
| FY2022 | 97.5M | +28.1% |
| FY2021 | 76.1M | +19.1% |
| FY2020 | 63.9M | +2.7% |
| FY2019 | 62.2M | +14.4% |
| FY2018 | 54.4M | +292.2% |
| FY2017 | 13.9M | +64.6% |
| FY2016 | 8.4M | +45.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026